United States:
FDA Issues Proposed Rule On Electronic Distribution Of Prescribing Information
20 January 2015
Jones Day
To print this article, all you need is to be registered or login on Mondaq.com.
In the December 18, 2014, Federal Register,
FDA proposed a rule amending its prescription drug and biological
product labeling regulations to require electronic distribution of
the prescribing information for health care professionals, which is
currently distributed in paper form on or within the package.
Comments due March 18, 2015.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
